WHO Director Tedros Adhanom Ghebreyesus announced at the press conference that WHO gave emergency use approval for the vaccine developed by AstraZeneca against Covid-19. WHO gave emergency use approval for two versions of the Oxford-AstraZeneca vaccine, allowing these vaccines to be rolled out worldwide through COVAX. Ghebreyesus announced that one of the vaccines was produced by SKBio in South Korea and the other by the Indian Serum Institute in India. Ghebreyesus reminded that WHO’s emergency use list evaluates and guarantees the quality, safety and effectiveness of their vaccines.
The number of cases worldwide has been declining for 5 weeks
Stating that Covid-19 cases worldwide have been in a downward trend for 5 consecutive weeks, Ghebreyesus stated that last week was the lowest number of weekly cases reported since October. “The number of cases reported weekly so far this year has dropped from more than 5 million cases on the week of January 4 to 2.6 million cases on the week of February 8, which is almost half in just 5 weeks,” Ghebreyesus said.
EBOA ALARM IN CONGO AND GUINEA
Ghebreyesus also announced that 4 Ebola cases were detected in Congo and 2 people died. Stating that Ebola cases were also detected in Guinea, Ghebreyesus said, “3 cases have been confirmed among 6 people who reported Ebola-like symptoms so far. 2 people died, the other 4 were treated at the hospital,” he said.
Ghebreyesus recalled that Guinea was one of three countries affected by the Ebola outbreak in West Africa from 2014 to 2016.